Selecta Biosciences Inc (NASDAQ:SELB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SELB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SELB

  • Market Cap$237.970m
  • SymbolNASDAQ:SELB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS8162121045

Company Profile

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover and develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.

Latest SELB news

Currently there for this company. Visit our news hub for other news .